A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) (REGENERATE-PD)

Investigator: William Ondo

Study Coordinator: Daniel Arnaud Dominguez

Status: Enrolling

ClinicalTrials.gov Number: NCT06285643

Phone: 346.356.3635

Protocol Number: PRO00038075

Description

The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson's Disease.